NEW YORK, Aug. 12, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Mercury Systems, Inc. MRCY
Lead Plaintiff Deadline: September 10, 2018
Class Period: October 24, 2017 and April 24, 2018
Get additional information about MRCY: http://www.wongesq.com/pslra-c/mercury-systems?wire=3
Glencore plc GLNCY GLCNF)
Lead Plaintiff Deadline: September 7, 2018
Class Period: September 30, 2016 and July 2, 2018
Get additional information about GLNCY: http://www.wongesq.com/pslra-c/glencore-plc?wire=3
MEDNAX, Inc. MD
Lead Plaintiff Deadline: September 10, 2018
Class Period: February 4, 2016 and July 27, 2017
Get additional information about MD: http://www.wongesq.com/pslra-c/mednax-inc?wire=3
Farmland Partners Inc. FPI
Lead Plaintiff Deadline: September 10, 2018
Class Period: May 9, 2017 and July 10, 2018
Get additional information about FPI: http://www.wongesq.com/pslra-c/farmland-partners-inc?wire=3
National Beverage Corp. FIZZ
Lead Plaintiff Deadline: September 17, 2018
Class Period: July 17, 2014 and July 3, 2018
Get additional information about FIZZ: http://www.wongesq.com/pslra-c/national-beverage-corp?wire=3
Sibanye Gold Limited SBGL
Lead Plaintiff Deadline: August 27, 2018
Class Period: April 7, 2017 and June 26, 2018
Get additional information about SBGL: http://www.wongesq.com/pslra-c/sibanye-gold-limited?wire=3
ACADIA Pharmaceuticals Inc. ACAD
Lead Plaintiff Deadline: September 17, 2018
Class Period: April 29, 2016 and July 9, 2018
Get additional information about ACAD: http://www.wongesq.com/pslra-c/acadia-pharmaceuticals-inc?wire=3
AbbVie Inc. ABBV
Lead Plaintiff Deadline: September 24, 2018
Class Period: May 30, 2018
Get additional information about ABBV: http://www.wongesq.com/pslra-c/abbvie-inc?wire=3
Tetraphase Pharmaceuticals, Inc. TTPH
Lead Plaintiff Deadline: September 25, 2018
Class Period: (1) Pursuant and/or traceable to the July 2017 Secondary Offering and/or (2) between March 8, 2017 and February 13, 2018
Get additional information about TTPH: http://www.wongesq.com/pslra-c/tetraphase-pharmaceuticals-inc?wire=3
Rockwell Medical, Inc. RMTI
Lead Plaintiff Deadline: September 25, 2018
Class Period: March 16, 2018 and June 26, 2018
Get additional information about RMTI: http://www.wongesq.com/pslra-c/rockwell-medical-inc?wire=3
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.